SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000701
Filing Date
2024-05-09
Accepted
2024-05-09 16:13:47
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20240331x10q.htm   iXBRL 10-Q 882321
2 EX-31.1 qnrx-20240331xex31d1.htm EX-31.1 14358
3 EX-31.2 qnrx-20240331xex31d2.htm EX-31.2 14340
4 EX-32.1 qnrx-20240331xex32d1.htm EX-32.1 5819
5 EX-32.2 qnrx-20240331xex32d2.htm EX-32.2 5826
  Complete submission text file 0001410578-24-000701.txt   4628315

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20240331.xsd EX-101.SCH 45607
7 EX-101.CAL qnrx-20240331_cal.xml EX-101.CAL 29702
8 EX-101.DEF qnrx-20240331_def.xml EX-101.DEF 180500
9 EX-101.LAB qnrx-20240331_lab.xml EX-101.LAB 361887
10 EX-101.PRE qnrx-20240331_pre.xml EX-101.PRE 280764
75 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20240331x10q_htm.xml XML 572868
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 24930787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)